Khiron drops revenue by 4% to $4.5M in Q2

Mugglehead
By Natalia Buendia CalvilloAug 29, 2022, 8:25 pm177 pts
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) says is continuing its momentum in the medical cannabis markets across the world. On Monday, the cannabis producer released its financial report for the quarter ended March June 30 and reported a net loss of $2.1 for the second quarter,…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Damien Cornwell: Leading Through Chaos in New York’s Cannabis Market 53

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.